1x Ab-conjugated beads (premixed). PN: C192207TA. One bottle containing 1.5 mL of the following AimPlex antibody-bead conjugates:
S4P3 - anti-human TNFα
S4P5 - anti-human IL-1β
S4P8 - anti-human IL-1RA
S4P10 - anti-human IL-8
S4P12 - anti-human IL-12p70
S5P6 - anti-human IL-6
S5P10 - anti-human IL-10
2x Biotin-detection Ab (premixed). PN: C192207TB. One vial containing 0.45 mL of the following biotinylated antibodies.
Biotin - anti-human TNFα
Biotin - anti -human IL-1β
Biotin - anti-human IL-1RA
Biotin - anti-human IL-8
Biotin - anti-human IL-12p70
Biotin - anti-human IL-6
Biotin - anti-human IL-10
2x NR dAb Diluent. PN: 07NDX21T. One vial containing 0.45 mL of biotin detection antibody diluent.
Lyophilized Standard Mix- Human Inflammation 7-Plex. PN: HG19107. One vial containing lyophilized recombinant IL-1β, IL-1RA, IL-8, IL-6, IL-10, TNFα, IL-12p70.
Standard Info Sheet: Indicates reconstitute volume and standard concentrations.
Basic Kit for Premixed Panels - 32 Tests:
1x Streptavidin-PE (SAPE). PN: 07SP0011T. One bottle containing 1 mL of 1x SAPE.
10x Reading Buffer. PN: 07RB1T. One bottle containing 1.5 mL of 10x buffer.
10x Wash Buffer. PN: 07WB1T. One vial containing 5 mL of 10x buffer.
PCR 8-tube Strip. PN: 07P8T1. 2 strips.
Filter Plate and Lid. PN: 07FPL1. 1 96- well filter plate and 1 plate lid.
Plate Seals. PN: 07PSR1. 3 sealers.
STORAGE: 2-8 C in the dark.
IMPORTANT: Sodium azide forms explosive compounds with heavy metals. These products contain <0.05% (w/w) azide which with repeated contact with lead and copper commonly found in plumbing drains may result in the buildup of shock sensitive compounds. Dispose in accordance with regulations from your institute.
APPLICATION: Optimal antibody pairs and antigen standards for assaying Inflammation 7-Plex Panel. To be used in conjunction with the AimPlex Basic Kit for Premixed Panels - 32 Tests (PN: U100005T) and a diluent kit. Refer to the AimPlex Multiplex Immunoassay User Manual and kit inserts for the assay procedure.
Sample types: Cell culture supernatant, serum, plasma, bodily fluid and tissue/cell lysate
Sensitivity (LODs): IL-1β, < 5 pg/mL; IL-1RA, < 5 pg/mL; IL-6, < 5 pg/mL; IL-8, < 1 pg/mL; IL-10, < 2 pg/mL; IL-12p70, < 3 pg/mL; TNFα, < 1 pg/mL.
LLOQs: IL-1β, < 10 pg/mL; IL-1RA, < 10 pg/mL; IL-6, < 10 pg/mL; IL-8, < 1 pg/mL; IL-10, < 5 pg/mL; IL-12p70, < 10 pg/mL; TNFα, < 2 pg/mL.
ULOQs: IL-1β, > 5,000 pg/mL; IL-1RA, < 2,000 pg/mL; IL-6, > 5,000 pg/mL; IL-8, > 1,000 pg/mL; IL-10, > 5,000 pg/mL; IL-12p70, > 2,000 pg/mL; TNFα, > 1,000 pg/mL.
Standard dose recovery: 70-130%
Intra-assay CV: < 10%
Inter-assay CV: < 20%
Cross-reactivity of analytes in the Panel: Negligible
Sample volume: 15 µL/test